z-logo
Premium
Renal outcome after simultaneous heart and kidney transplantation
Author(s) -
Toinet Théodore,
Dominique Inès,
Cholley Irène,
Vanalderwerelt Victor,
Goujon Anna,
Paret Fanny,
Bessede Thomas,
Delaporte Véronique,
Salomon Laurent,
Badet Lionel,
Boutin JeanMichel,
Verhoest Gregory,
Branchereau Julien,
Timsit MarcOlivier
Publication year - 2019
Publication title -
clinical transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 76
eISSN - 1399-0012
pISSN - 0902-0063
DOI - 10.1111/ctr.13615
Subject(s) - medicine , dialysis , renal function , transplantation , kidney transplantation , perioperative , retrospective cohort study , kidney , heart transplantation , heart failure , surgery , urology
Simultaneous heart‐kidney transplant (HKTx) is a valid treatment for patients with coexisting heart and renal failure. The aim of this study was to assess renal outcome in HKTx and to identify predictive factors for renal loss. A retrospective study was conducted among 73 HKTx recipients: Donors’ and recipients' records were reviewed to evaluate patients’ and renal transplants’ survival and their prognostic factors. The mean follow‐up was 5.36 years. Renal primary non‐function occurred in 2.7%, and complications Clavien IIIb or higher were observed in 67.1% including 16 (22%) postoperative deaths. Five‐year overall survival and renal survival were 74.5% and 69.4%. Among survivors, seven returned to dialysis during follow‐up. The postoperative use of ECMO (HR = 6.04, P  = 0.006), dialysis (HR = 1.04/day, P  = 0.022), and occurrence of complications (HR = 31.79, P  = 0.022) were independent predictors of postoperative mortality but not the history of previous HTx or KTx nor renal function prior to transplantation. History of KTx (HR = 2.52, P  = 0.026) and increased delay between the two transplantations (HR = 1.25/hour, P  = 0.018) were associated with renal transplant failure. HKTx provides good renal transplant survival and function, among survivors. Early mortality rate of 22% underlines the need to identify perioperative risk factors that would lead to more judicious and responsible allocation of a scarce resource.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom